John Shields

Senior Advisor

  • LocationLondon

John provides Abingworth with scientific and technical advice and is often the first filter for an investment proposal. Prior to joining Abingworth he held positions at Cantab Pharmaceuticals as Senior Vice President, Research, the Glaxo Institute for Molecular Biology and the Institute of Child Health, UCL.

In addition, John is on the Edinburgh BioQuarter Board, the MRC Translational Research Group committee, the BHF Translational Award Advisory Group, the Biomedical Catalyst Major Awards Committee and the Sanger Centre Translational Committee. He has a PhD in Immunology from the University of Glasgow and has published more than 30 papers in peer-reviewed journals including Science.